Title: Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging
Authors: Van Laere, Koen ×
de Hoon, Jan
Bormans, Guy
Koole, Michel
Derdelinckx, Inge
De Lepeleire, I
Declercq, R
Sanabria Bohorquez, S M
Hamill, T
Mozley, P D
Tatosian, D
Xie, W
Liu, Y
Liu, F
Zappacosta, P
Mahon, C
Butterfield, K L
Rosen, L B
Murphy, M G
Hargreaves, R J
Wagner, J A
Shadle, C R #
Issue Date: Aug-2012
Publisher: Mosby
Series Title: Clinical pharmacology and therapeutics vol:92 issue:2 pages:243-250
Article number: 10.1038/clpt.2012.62
Abstract: The type 1 neurokinin receptor (NK1R) antagonist aprepitant and its i.v. prodrug fosaprepitant have been approved for prevention of acute and delayed nausea and vomiting associated with chemotherapy. This study evaluated the magnitude and duration of brain NK1R occupancy over a period of 5 days after single-dose i.v. infusion of 150-mg fosaprepitant and single-dose oral administration of 165-mg aprepitant, using serial [(18)F]MK-0999 positron emission tomography (PET) in 16 healthy subjects. Each subject underwent three scans. Brain NK1R occupancy rates after i.v. fosaprepitant at time to peak concentration (T(max); ~30 min), 24, 48, and 120 h after the dose were 100, 100, ≥97, and 41-75%, respectively. After aprepitant, NK1R occupancy rates at these time points (T(max) ~4 h) were ≥99, ≥99, ≥97, and 37-76%, respectively. Aprepitant plasma concentration profiles were comparable for the two dosage forms. The study illustrates the utility of PET imaging in determining central bioequivalence in a limited number of subjects.
ISSN: 0009-9236
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical Pharmacology Centre (-)
Nuclear Medicine & Molecular Imaging
Laboratory for Clinical Infectious and Inflammatory Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science